Clinical Trial Update: Neutrophile Gelatinase Associated Lipocalin Evaluation in Septic Acute Kidney Injury

View source ↗

Summary

A clinical trial update examining neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker in septic acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Sepsis

Snippet

Sponsor: Université Victor Segalen Bordeaux 2 | Conditions: Acute Kidney Failure | Status: UNKNOWN